[
    [
        {
            "time": "2021-10-06",
            "original_text": "复星医药新品进入II期临床 半年投入17.77亿研发“下猛药”",
            "features": {
                "keywords": [
                    "复星医药",
                    "新品",
                    "II期临床",
                    "研发投入",
                    "17.77亿"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药新品进入II期临床 半年投入17.77亿研发“下猛药”",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-06",
            "original_text": "陆家嘴财经早餐2021年10月6日星期三",
            "features": {
                "keywords": [
                    "陆家嘴",
                    "财经早餐"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "陆家嘴财经早餐2021年10月6日星期三",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 2,
                "Headline_Structure": 5,
                "Source_Recency": 1
            }
        },
        {
            "time": "2021-10-06",
            "original_text": "复星医药VS恒瑞医药～恒瑞在行业还是有很高地位的，综合实力很强",
            "features": {
                "keywords": [
                    "复星医药",
                    "恒瑞医药",
                    "行业地位",
                    "综合实力"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药VS恒瑞医药～恒瑞在行业还是有很高地位的，综合实力很强",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-10-06",
            "original_text": "复星医药VS西藏药业～复兴在西藏面前胜负比只有4:8？",
            "features": {
                "keywords": [
                    "复星医药",
                    "西藏药业",
                    "胜负比",
                    "4:8"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药VS西藏药业～复兴在西藏面前胜负比只有4:8？",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]